ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,824 | -85.4% | 611 | -72.0% | 0.00% | – |
| Q2 2023 | $46,652 | -54.4% | 2,180 | -13.9% | 0.00% | – |
| Q1 2023 | $102,394 | -36.6% | 2,532 | -27.1% | 0.00% | – |
| Q4 2022 | $161,517 | -43.7% | 3,472 | -37.3% | 0.00% | -100.0% |
| Q3 2022 | $287,000 | +103.5% | 5,537 | +85.5% | 0.00% | – |
| Q2 2022 | $141,000 | -88.9% | 2,985 | -83.3% | 0.00% | -100.0% |
| Q1 2022 | $1,269,000 | +14.0% | 17,831 | +19.7% | 0.00% | +100.0% |
| Q4 2021 | $1,113,000 | – | 14,895 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |